AIM2 and neoplasm: AIM2 inflammasomes scores were positively correlated with tumor mutation burden (TMB) in GBM, UVM, PCPG, UCS, KICH, LGG, READ, HNSC, THCA, KIRC, SKCM, STAD, COAD, MESO, BRCA, SARC, CESC, LIHC, KIRP, PAAD, ESCA, BLCA, UCEC, PRAD, LUSC, and OV (all P < 0.05) (Figure 12A).